Published in Acta Oncol on October 01, 2010
Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US. J Transl Med (2015) 1.39
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity. Synapse (2012) 0.93
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H. Acta Oncol (2013) 0.86
Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nucl Med Mol Imaging (2013) 0.75
Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET. Comput Math Methods Med (2015) 0.75
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study. Lancet Oncol (2010) 2.09
Hierarchical modularity and the evolution of genetic interactomes across species. Mol Cell (2012) 1.88
Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys (2013) 1.52
Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. FASEB J (2006) 1.40
Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol (2010) 1.21
Quality assurance of dosimetry and the impact on sample size in randomized clinical trials. Radiother Oncol (2007) 1.18
Intracellular metabolic compartmentation assessed by 13C magnetic resonance spectroscopy. Neurochem Int (2004) 1.16
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One (2010) 1.15
Telemedicine in radiotherapy: a study exploring remote treatment planning, supervision and economics. J Telemed Telecare (2005) 1.14
Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study. Phys Med Biol (2006) 1.08
Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy. Radiother Oncol (2013) 1.07
Novel EDA mutation resulting in X-linked non-syndromic hypodontia and the pattern of EDA-associated isolated tooth agenesis. Eur J Med Genet (2008) 1.03
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther (2011) 1.03
Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res (2012) 1.02
Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys (2010) 1.02
IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int (2009) 1.01
Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol (2005) 0.99
Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys (2007) 0.99
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium. J Enzyme Inhib Med Chem (2014) 0.96
PathLocdb: a comprehensive database for the subcellular localization of metabolic pathways and its application to multiple localization analysis. BMC Genomics (2010) 0.95
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res (2013) 0.95
TSdb: a database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates. Sci China Life Sci (2011) 0.95
Classification of dynamic contrast enhanced MR images of cervical cancers using texture analysis and support vector machines. IEEE Trans Med Imaging (2014) 0.95
Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors. BMC Genomics (2009) 0.95
Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol (2014) 0.94
STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer. Cancer Res (2010) 0.93
EDdb: a web resource for eating disorder and its application to identify an extended adipocytokine signaling pathway related to eating disorder. Sci China Life Sci (2013) 0.93
High similarity of phylogenetic profiles of rate-limiting enzymes with inhibitory relation in Human, Mouse, Rat, budding Yeast and E. coli. BMC Genomics (2011) 0.93
Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype. Int J Cancer (2005) 0.92
Pyruvate recycling in cultured neurons from cerebellum. J Neurosci Res (2007) 0.92
Exploiting the transcriptome of Euphrates Poplar, Populus euphratica (Salicaceae) to develop and characterize new EST-SSR markers and construct an EST-SSR database. PLoS One (2013) 0.92
The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types. Endocrinology (2004) 0.91
Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations. Eur Radiol (2012) 0.91
A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. J Biol Chem (2004) 0.91
Tumor-line specific pO(2) fluctuations in human melanoma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.91
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Res (2014) 0.91
Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J Pharmacol Exp Ther (2002) 0.90
Strategies for biologic image-guided dose escalation: a review. Int J Radiat Oncol Biol Phys (2009) 0.89
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer. Proc Natl Acad Sci U S A (2013) 0.89
IQdb: an intelligence quotient score-associated gene resource for human intelligence. Database (Oxford) (2013) 0.89
Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int (2005) 0.89
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy. Radiat Oncol (2011) 0.88
Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations. Clin Cancer Res (2013) 0.88
Glutamate is preferred over glutamine for intermediary metabolism in cultured cerebellar neurons. J Cereb Blood Flow Metab (2006) 0.88
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol (2013) 0.88
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma. PLoS One (2013) 0.88
Metabolic plasticity in the supraspinal pain modulating circuitry after noxious stimulus-induced spinal cord LTP. Pain (2008) 0.87
Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci (2011) 0.87
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts. Radiat Oncol (2011) 0.87
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity? Radiother Oncol (2007) 0.86
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H. Acta Oncol (2013) 0.86
In vivo mapping of temporospatial changes in manganese enhancement in rat brain during epileptogenesis. Neuroimage (2007) 0.86
Cloning of a novel aldo-keto reductase gene from Klebsiella sp. strain F51-1-2 and its functional expression in Escherichia coli. Appl Environ Microbiol (2007) 0.86
Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients. Am J Pathol (2010) 0.85
Do mosquitoes acquire organophosphate resistance by functional changes in carboxylesterases? FASEB J (2007) 0.85
Demonstration of pyruvate recycling in primary cultures of neocortical astrocytes but not in neurons. Neurochem Res (2002) 0.85
Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation. Int J Radiat Biol (2012) 0.85
Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT. Mol Imaging Biol (2011) 0.85
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice. Anticancer Res (2009) 0.85
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. Mol Oncol (2012) 0.84
Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases. Biol Chem (2009) 0.84
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncol (2013) 0.84
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer. Int J Radiat Oncol Biol Phys (2013) 0.84
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer. Radiat Oncol (2012) 0.84
Astrocyte metabolism is disturbed in the early development of experimental hydrocephalus. J Neurochem (2003) 0.84
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance. Int J Radiat Oncol Biol Phys (2011) 0.84
Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy. Neurochem Res (2007) 0.83
Adapting biological feedback in radiotherapy. Semin Radiat Oncol (2010) 0.83
Reduced astrocytic contribution to the turnover of glutamate, glutamine, and GABA characterizes the latent phase in the kainate model of temporal lobe epilepsy. J Cereb Blood Flow Metab (2011) 0.83
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma. Radiat Oncol (2012) 0.83
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol (2010) 0.83
EPR dosimetric properties of formates. Appl Radiat Isot (2003) 0.83
Dose Distribution in the Heart and Cardiac Chambers Following 4-field Radiation Therapy of Breast Cancer: a Retrospective Study. Breast Cancer (Auckl) (2013) 0.82
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers. Acta Oncol (2011) 0.82
Side effects and quality of life after inadvertent radiation overdosage in brachytherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 0.82
Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation. Biol Chem (2009) 0.82
Roles of PINCH-2 in regulation of glomerular cell shape change and fibronectin matrix deposition. Am J Physiol Renal Physiol (2008) 0.82
Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study. Radiat Oncol (2011) 0.82
Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population. PLoS One (2013) 0.82
ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner. J Biol Chem (2011) 0.81
Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089. J Steroid Biochem Mol Biol (2004) 0.81
Ventricular diverticulum: a review of the literature. J Card Surg (2013) 0.81
Arabidopsis NMD3 is required for nuclear export of 60S ribosomal subunits and affects secondary cell wall thickening. PLoS One (2012) 0.81
G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells. Eur J Haematol (2011) 0.80
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts. Int J Cancer (2011) 0.80
Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation. Acta Oncol (2008) 0.80
Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy. Acta Oncol (2013) 0.80
Acute changes in intermediary metabolism in cerebellum and contralateral hemisphere following middle cerebral artery occlusion in rat. J Neurochem (2009) 0.80
Annexin A7 gene is an important factor in the lymphatic metastasis of tumors. Biomed Pharmacother (2012) 0.80
Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncol (2013) 0.79